Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Biophytis Completes €2 Million B Round Financing - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Biophytis Completes €2 Million B Round Financing

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

In an effort to continue the development of its nutraceutical and drug pipeline, Biophytis, a research company that focuses on metabolic disorders and age-related diseases, has raised €2 million ($2.6 million) in a B round. Metabrain Research, a spin-off of Merck Serono based in Chilly-Mazarin, France, joined existing investors Seventure partners and CM-CIC Capital Prive in this round. 
Biophytis’ first project, SARCOB, targets the treatment of sarcopenic obesity, in partnership with the Myology Institute and Institute of Cardio-metabolism and Nutrition, both at the University of Pierre and Marie Curie (UPMC), and France’s national agricultural research institute, INRA. The second project, MACULIA, focuses on treating age-related macular degeneration, in collaboration with UPMC’s Institut de la Vision and Iris Pharma, a contract research organization dedicated to ophthalmology. Biophytis leads these two projects, which are sponsored by the Medicen competitivity cluster in the Paris region that benefit from grants of €2.3 million EUR from a number of European and French local and national government bodies.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics